Director of the Non-Communicable Diseases in Conflict Program at the Harvard Humanitarian Initiative.
1 published article
Dr. Kehlenbrink is an Endocrinologist and Director of Global Endocrinology at Brigham and Women’s Hospital, Instructor at Harvard Medical School, and Director of the Non-Communicable Diseases in Conflict Program at the Harvard Humanitarian Initiative.
Her research focusses on diabetes care in humanitarian settings and improving insulin access in low- and middle-income settings. She leads the HUmanitarian NCD InTeragency study in Emergencies and Disasters (UNITED) study with five humanitarian organizations. In April 2019 she organized the Symposium on Diabetes in Humanitarian Crises at Harvard University which convened leaders in global health to discuss the immediate needs and barriers to tackling diabetes in humanitarian crises, and adopt a unified, action-oriented agenda. The meeting resulted in the Boston Declaration, published in The Lancet Diabetes & Endocrinology, which outlines four target areas that the 64 signatories seek to address over the next years. She now leads a new consortium which seeks to address the targets in the Boston Declaration.